Table 2.
Variable | Metabolic Syndrome, N = 1070 (53.9%) | No Metabolic Syndrome, N = 914 (46.1%) | Difference of Changec (95% CI) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
na | Change from Baselineb (mean ± SD) | P | na | Change from Baselineb (mean ± SD) | P | Unadjusted | P | Adjustedd | P | |
Body composition | ||||||||||
Weight, lbs | 716 | −4.68 ± 8.68 | < 0.0001 | 636 | −3.58 ± 7.37 | < 0.0001 | −1.10 (−1.96, −0.24) | 0.01 | −1.43 (−2.31, −0.56) | 0.001 |
Body mass index, kg/m2 | 714 | −0.74 ± 1.82 | < 0.0001 | 635 | −0.56 ± 1.43 | < 0.0001 | −0.18 (−0.35, −0.01) | 0.04 | −0.21 (−0.37, −0.03) | 0.02 |
Body fat percentage | 619 | −0.82 ± 3.23 | < 0.0001 | 553 | −0.57 ± 2.28 | < 0.0001 | −0.24 (−0.56, 0.07) | 0.13 | −0.31 (−0.63, 0.01) | 0.06 |
Metabolic syndrome components | ||||||||||
Waist circumference, in | 628 | −0.81 ± 1.99 | < 0.0001 | 545 | −0.57 ± 1.94 | < 0.0001 | −0.24 (−0.46, −0.01) | 0.04 | −0.31 (−0.54, −0.08) | 0.008 |
HDL-C, mg/dL | 578 | 2.14 ± 6.73 | < 0.0001 | 487 | 2.68 ± 8.15 | < 0.0001 | −0.54 (−1.45, 0.37) | 0.24 | −0.20 (−1.13, 0.73) | 0.67 |
Triglycerides, mg/dL | 578 | −14.41 ± 61.05 | < 0.0001 | 487 | −5.09 ± 43.63 | 0.0001 | −9.32 (−15.62, −3.02) | 0.004 | −8.70 (−15.04, −2.37) | 0.007 |
Fasting glucose, mg/dL | 375 | −3.78 ± 37.03 | 0.001 | 167 | 1.74 ± 20.03 | 0.42 | −5.52 (−10.33, −0.70) | 0.02 | −5.48 (−10.44, −0.53) | 0.03 |
Systolic BP, mm Hg | 715 | −2.38 ± 17.68 | 0.002 | 630 | −0.37 ± 16.49 | 0.70 | −2.01 (−3.83, −0.18) | 0.03 | −1.68 (−3.55, 0.18) | 0.08 |
Diastolic BP, mm Hg | 715 | −1.11 ± 10.59 | 0.008 | 628 | −0.98 ± 10.27 | 0.05 | −0.13 (−1.25, 0.99) | 0.82 | −0.26 (−1.41, 0.89) | 0.66 |
Other lipids, mg/dL | ||||||||||
Total cholesterol | 578 | −0.08 ± 31.97 | 0.62 | 487 | −1.20 ± 28.59 | 0.84 | 1.12 (−2.51, 4.76) | 0.54 | 0.94 (−2.81, 4.69) | 0.62 |
LDL-C | 577 | −19.59 ± 29.06 | < 0.0001 | 486 | −16.97 ± 28.85 | < 0.0001 | −2.62 (−6.11, 0.87) | 0.14 | −1.50 (−5.06, 2.05) | 0.41 |
Non-HDL-C | 578 | −2.21 ± 30.33 | 0.11 | 487 | −3.82 ± 26.54 | 0.002 | 1.61 (−1.81, 5.02) | 0.36 | 1.08 (−2.43, 4.60) | 0.55 |
Psychosocial health, mean ± SD | ||||||||||
BSI-53 global severity index | 654 | −3.66 ± 7.64 | < 0.0001 | 572 | −4.50 ± 7.76 | < 0.0001 | 0.84 (−0.02, 1.71) | 0.06 | 0.82 (−0.06, 1.71) | 0.07 |
BSI-53 depression score | 654 | −1.67 ± 7.75 | < 0.0001 | 572 | −2.51 ± 7.14 | < 0.0001 | 0.84 (0.00, 1.67) | 0.05 | 0.92 (0.08, 1.76) | 0.03 |
BSI-53 anxiety score | 654 | −3.32 ± 8.66 | < 0.0001 | 572 | −3.99 ± 8.59 | < 0.0001 | 0.67 (−0.30, 1.63) | 0.18 | 0.60 (−0.37, 1.57) | 0.23 |
BSI-53 hostility score | 654 | −2.79 ± 8.00 | < 0.0001 | 572 | −2.26 ± 7.99 | < 0.0001 | −0.54 (−1.43, 0.36) | 0.24 | −0.39 (−1.32, 0.54) | 0.41 |
Cardiopulmonary fitness | ||||||||||
RPE | 485 | −3.02 ± 3.04 | < 0.0001 | 447 | −3.53 ± 6.77 | < 0.0001 | 0.51 (−0.17, 1.19) | 0.14 | 0.34 (−0.26, 0.93) | 0.27 |
Notes: aNumber of patients with data at both baseline and end of program. bFrom Wilcoxon signed-rank tests. cFrom difference-in-differences regression models specifying robust estimates of variance. Patients without metabolic syndrome are treated as the reference. dDerived from difference-in-differences models adjusted for age, sex, education, employment status, and indication for referral to cardiac rehab.
Abbreviations: SD, standard deviation; CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; BSI, brief symptom inventory; METs, metabolic equivalents; RPE, rating of perceived exertion.